Myasthenia Gravis
Latest scientific, peer-reviewed articles focusing on Myasthenia Gravis.
Filter Results
Lower number of plasma exchange sessions and glomerular filtration rate decline are associated with second relapses in patients with myasthenia gravis
The aims were to determine the impact of dysphagia and glomerular filtration rate (GFR) in the prediction of myasthenia relapse and analyse whether different number of plasma exchange sessions could prolong the time before future relapse.
Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life
Myasthenia gravis (MG) may be refractory to traditional therapies. Quality of life (QOL) and disease burden in patients with refractory and nonrefractory MG were compared using Myasthenia Gravis Foundation of America MG Patient Registry data.
Intrathymic Plasmablasts Are Affected in Patients With Myasthenia Gravis With Active Disease
To investigate intrathymic B lymphopoiesis in patients with myasthenia gravis (MG) and explore thymus pathology associated with clinical impact.
Newly diagnosed multiple sclerosis in a patient with ocular myasthenia gravis A case report
Patients with myasthenia gravis may also have comorbid autoimmune diseases. Since both myasthenia gravis and neuromyelitis optica spectrum disease are mediated by antibodies, they are likely to occur together.
High-Resolution Esophageal Manometry in Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that affects the postsynaptic membrane at the neuromuscular junction.
Prognostic factors for conversion to generalization in ocular myasthenia gravis
Patients with ocular myasthenia gravis (OMG) are frequently treated to prevent the development of generalized myasthenia gravis (GMG).
Diagnostic yields and clinical features of ocular myasthenia gravis
Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction, it is characterized by exertional weakness and fatigability.
Serum uric acid levels in patients with myasthenia gravis are inversely correlated with disability
Uric acid (UA), the final product of purine metabolism, has been reported to be reduced in patients with various neurological disorders and is considered to be a possible indicator for monitoring the disability and progression of multiple sclerosis.
FcRn: A Critical Role in gMG
Generalized myasthenia gravis is an autoimmune disorder of the musculoskeletal system caused by pathogenic immunoglobulin G autoantibodies. Learn More
